Pharmabiz

VarmX receives phase 1 waiver from Japanese medicines regulator PMDA for lead asset VMX-C001

VarmX receives phase 1 waiver from Japanese medicines regulator PMDA for lead asset VMX-C001: Leiden, The Netherlands Saturday, September 27, 2025, 18:00 Hrs [IST] VarmX, a biotec ...
Pharmabiz

US FDA approves Corstasis Therapeutics’ Enbumyst to treat edema associated with congestive heart failure, liver disease and kidney disease

Henderson, Nevada Saturday, September 27, 2025, 17:00 Hrs [IST] ...
Pharmabiz

NIH establishes nation's first dedicated organoid development centre to reduce reliance on animal modelling

NIH establishes nation's first dedicated organoid development centre to reduce reliance on animal modelling: Bethesda, Maryland Saturday, September 27, 2025, 16:00 Hrs [IST] The N ...
Pharmabiz

Veterinary vaccine manufacturers forms association

Veterinary vaccine manufacturers in the country have come together to announce the formation of the Veterinary Vaccine India Manufacturers Association (VVIMA), a not-for-profit organization that will ...
Pharmabiz

US FDA approves Eli Lilly’s Inluriyo for adults with ER+, HER2-, ESR1-mutated advanced or metastatic breast cancer

US FDA approves Eli Lilly’s Inluriyo for adults with ER+, HER2-, ESR1-mutated advanced or metastatic breast cancer: Indianapolis Saturday, September 27, 2025, 15:00 Hrs [IST] El ...